biotech
FDA Approxes ATryn, First Drug from a Genetically Engineered Animal
Filed in archive Diagnostics, Methodologies and Instrumentation , Genomics, Proteomics and Bioinformatics , Other Biotechnology News by ruth on February 7, 2009
FDA Approxes ATryn, First Drug from a Genetically Engineered Animal
The Food and Drug Authority has approved ATryn, the first ever transgenically produced therapeutic protein and the first recombinant antithrombin approved in the U.S.

ATryn is indicated for the treatment of patients with hereditary antithrombin deficiency, undergoing high-risk surgical or childbirth procedures. GTC Theapeutics has collaborated with OVATION Pharmaceuticals, Inc. to develop and market ATryn® in the United States.



Permalink: FDA Approxes ATryn, First Drug from a Genetically Engineered Animal
Tags: transgenics  atryn  genetics  genetic+engineering  antithrombin  blood+clotting  section  noscript+section 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/142858
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for FDA Approxes ATryn, First Drug from a Genetically Engineered Animal:

  • Currently 9.00/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 9.00 out of 1 vote(s) cast.
 
Subscribe
Share It
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!